Novo-Nordisk A/S
Market cap $191.0B
$43.34
NVO
$43.34
+0.23% today
Buy with €1M virtual cash · No real money
Novo-Nordisk A/S (NVO) is a publicly traded company listed on the XNYS. As of September 19, 2026, Invest's signal rates NVO a Sell, with the stock down 26% over the past year. You can practice trading NVO risk-free with €1,000,000 in virtual cash.
Key stats
As of September 19, 2026
Market Cap
$191.0B
Volume
10.4M
52-wk High
$64.16
52-wk Low
$35.12
Day High
$43.54
Day Low
$42.78
Performance
1M
-6.8%
6M
+16.9%
1Y
-25.5%
Invest signal · NVO
SellAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
NVO overview
AI overviewLatest NVO news
Novo's Denecimig Gets CHMP Nod for Hemophilia A in the European Union
Zacks Investment Research · 19h ago
Riyadh Global Medical Biotechnology Summit 2026 Closes as a Major Success with SAR 5.5 Billion in Agreements and announcement, Confirming Saudi Arabia's Commitment to Lead the Future of Biotechnology
GlobeNewswire Inc. · 1d ago
LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious?
Zacks Investment Research · 1d ago
This Trend is Excellent News for Eli Lilly and Its Investors
The Motley Fool · 2d ago
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks Investment Research · 2d ago
About Novo-Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Employees
69,500
30-Day Win Rate · NVO
10 days
13 days
Last 23 sessions
How to practice trading NVO
- 1
Use the NVO buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top NVO traders on Invest
Full leaderboardFrequently asked questions
Is NVO a good stock to buy right now?
As of September 19, 2026, Invest's signal rates NVO a Sell, based on its price trend, valuation, and fundamentals, with the stock down 26% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading NVO risk-free first.
What is Novo-Nordisk A/S's (NVO) market cap?
Novo-Nordisk A/S has a market capitalization of approximately $191.0B.
How has NVO stock performed?
NVO is down 26% over the past year and up 17% over six months. Its 52-week range runs roughly from $35.12 to $64.16. Past performance doesn't predict future results.
How can I practice trading NVO for free?
On Invest you get €1,000,000 in virtual cash and can buy NVO at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare NVO with peers